Parent Page: News id: 26727 Active Page: details id: 26917


OUHSC Research News – Monday, November 7, 2022

Published: Friday, November 4, 2022

OUHSC Research News – Monday, November 7, 2022

Workshops and Seminars

17th Annual Pediatric Research Day

Date: Friday, January 20, 2023

Venue: Samis Education Center

Deadline for abstract submission: Wednesday, November 16, 2022

Description: Pediatric Research Day, Sponsored by Children’s Health Foundation, highlights various types of research, case reports, advocacy and QI projects informing on neonatal/adolescent development, pediatric care, and pathogenesis/treatment of pediatric diseases to showcase medical and graduate trainees, share mutual interests, and initiate collaborative ideas. Individuals outside the Department of Pediatrics are highly encouraged to participate. Contact or should you have any questions or need clarification.

Link to the event page: Pediatrics Research Day


Bioinformatics and Computational Biology Mini-Symposium

Breakout Sessions on Special Topics

To Foster Interdisciplinary Research and Education in Bioinformatics and Computational Biology between Engineering, Science, and Medicine

Day/Time: November 18, 2022 (FRIDAY); 9:00 AM To 4:30 PM

Venue: Forum Building, OU, Norman

Description: A mini-symposium is being planned at the OU-Norman campus to bring together Bioinformatics and Computational Biology researchers from both the OU-Norman and OUHSC campuses. This mini-symposium aims to establish collaborations between OUHSC researchers performing Omics analyses with bioinformatics researchers at OU-Norman so that together we can build a highly skilled workforce for Omics data analyses, including single-cell RNA sequencing and spatial transcriptomics. At the symposium, we will highlight current work in the single-cell Omics field at OUHSC and provide an overview of how high-end computational approaches to Omics could further biomedical research projects on both campuses. Overall, we aim to foster collaboration in research and education, increase the understanding of state-of-the-art Omics tools and techniques, and explore avenues for increasing our bioinformatics and computationally skilled workforce to support Bioinformatics/Computational Biology analyses on the OUHSC and OU-Norman campuses. If you are currently performing Omics research, plan to perform Omics research, or are interested in learning about Omics research, please click on the link below to register. Lunch and refreshments will be provided.



9am: Introduction and welcome

9:15am – 12 noon: Short 20 minutes talks on biological applications of omics.

12-1:15pm: Lunch/keynote speaker.

1:30-3: Breakout sessions:

• Talent Development for the Omics World!

• AI development for omics

• Funding opportunities [public, private, foundation]

3:00 – 4:30: Possible Poster Sessions




Registration Deadline: November 27, 2022

Description: OU Health Stephenson Cancer Center is proud to host the 2022 END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer conference from December 1-2, 2022 in Oklahoma City, Oklahoma, USA.
The END2CANCER conference will start the morning of December 1, 2022 and conclude in the afternoon of December 2, 2022. The conference will bridge laboratory research conducted in the areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis, imaging and treatment of cancer. The conference will host keynote, plenary and invited lectures by eminent scientists who will discuss new and emerging concepts, technologies and challenges in translating nanomedicine from bench-to-bedside.
Topics to be discussed in the planned thematic sessions include Gene and Drug Delivery, Immuno-Oncology, Drug Discovery and New Drugs on the Horizon for Clinical Translation, Extracellular Vesicles, Combinatorial Therapeutics, and more to come. 
The multi-disciplinary two-day conference will bring together physicians, basic scientists, engineers, physicists, chemists, post-doctoral fellows, high-school and college students, patient advocates, business professionals, educators and technology transfer specialists. Students and fellows will have an opportunity to present their work and compete for cash awards. We will again be hosting a special session titled "Art of Science in Light of Nanomedicine" will allow participants to display their best research as a photo with a caption and compete for a cash prize.

We will be hosting a reception and dinner at the Devon Boathouse on Dec. 1 from 6:30 to 9:30 p.m.
Please RSVP by Nov. 22 if you wish to attend:



Harold Hamm Diabetes Center (HHDC) Research Symposium

Description: HHDC 2022 Research Symposium will be held on Friday, November 11, 2022 at the Samis Education Center in Children’s Hospital in Oklahoma City.  The Symposium will consist of selected oral presentations, a guest speaker speech by Julia Busik, PhD, Professor, Department of Physiology, College of Natural Science, Michigan State University, and a keynote address by Alvin C. Powers, MD, Joe C. Davis Chair in Biomedical Science, Medicine, and Molecular Physiology and Biophysics Professor, Vanderbilt Diabetes Center Director, Division of Diabetes and Endocrinology, Vanderbilt University.  To RSVP for this free event, please go to:

Please contact with any questions about this event.


The National Symposium on Sexual Behavior of Youth Call for Poster Abstracts

Description: Join your colleagues on Wednesday, February 22, 2023 from 5:00p - 7:00p for the multi-disciplinary NSSBY poster session that will highlight the latest research, programs, and activities in the field.  Light snacks will be available during the poster session, which will be concurrent with the Welcome Reception.  The poster session provides opportunities for extended discussion with symposium participants about your work.
Poster submissions must be received by November 30, 2022.  Announcements of acceptance will be made by December 15, 2022.  
Posters describing innovative programs and implementation strategies are encouraged and welcomed.  Posters can focus on a wide variety of topics related to the sexual behavior of youth, such as:

  • sexual development
  • sex education
  • healthy sexual behavior
  • impact of technology
  • problematic/harmful and/or illegal sexual behavior
  • assessment
  • treatment
  • long-term outcomes

More information can be found at:



OUHSC Funding Opportunities

Call for Applications: PHF Equipment, Symposium, and Seed Grant Programs


Grant Type



November 30, 2022


November 30, 2022


December 2, 2022








Presbyterian Health Foundation (PHF) Equipment Grant Program – Request For Applications

  • Cycle I PHF Equipment Grant Program Deadline: November 30, 2022

The primary objective of the PHF Equipment Grant program is to provide partial funding for critically needed research equipment. Funding priority will be given to research equipment that will permit OUHSC investigators to be more competitive for external funding and provides support to multiple users. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) All Assistant, Associate, or Full Professors are eligible to apply.; 2) Principal investigators with Temporary Faculty appointments (faculty with academic titles such as instructor, lecturer, or titles modified by prefixes, such as visiting, adjunct, clinical, or temporary research appointments with suffix “of Research”) must obtain approval from the Vice President for Research before submitting an application for this program. Requests should be sent to; 3) PHF Equipment Grant recipients may hold any other PHF Grant award simultaneously, except for a Clinician Scientist Development Award. 


Presbyterian Health Foundation (PHF) Symposium Grant Program – Request For Applications

  • Cycle I PHF Symposium Grant Program Deadline: November 30, 2022

The primary objective of the PHF Symposium Grant program is to provide partial funding to support a National or International Symposium to be held at the OUHSC campus or in Oklahoma City. Funding priority will be given to themes that will promote research already present at OUHSC and OMRF and include both OUHSC faculty members and OMRF members in the Organization Committee. OUHSC Principal Investigators are eligible to apply if they meet the following criteria: 1) The Principal Investigator of the application must be the Chair of the Organizing Committee. Only OUHSC full-time, tenure-track faculty members (unmodified titles) are eligible to be PIs. 2). The PI may hold any other PHF Grant award, except for a Clinician Scientist Development Award.

Presbyterian Health Foundation (PHF) Seed Grant Program – Request For Applications

  • Cycle I PHF Seed Grant Program Deadline: December 2, 2022

The primary objective of the PHF Seed Grant program is to provide a one-year grant for new OUHSC investigators to initiate research programs. Secondary objectives are to provide established OUHSC faculty with the opportunity to initiate new unfunded projects and to provide unfunded OUHSC faculty funds to initiate a research program. Applications from new investigators (within 5 years of first full academic appointment and never having received independent federal funds) are given special consideration during peer review and at the time of funding consideration. Principal Investigators with Temporary Faculty appointments (faculty with academic titles such as instructor, lecturer, or titles modified by prefixes such as visiting, adjunct, clinical, or temporary research appointments with suffix “of Research”) must obtain approval from the Vice President for Research before submitting an application for this program. Approval will require a letter from their Department Chairperson indicating a departmental commitment of salary, research space, and time for development of an independent career at OUHSC.  Requests should be sent to PHF Seed Grant recipients may not hold a PHF Bridge Grant or a PHF Clinician Scientist Development Grant during the duration of this award.

IMPORTANT UPDATE: This PHF Seed Grant program can now provide funding for up to $75,000 for one year. SALARY and FRINGE BENEFITS may be requested for the Principal Investigator(s) up to $25,000 in total (salary + fringe benefits = $25,000) with the remaining portion, $50,000, used to support the project costs.

Guidelines and Application Forms are attached or can be found at If you have any questions, please email


Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email or  

  • Modelez International is seeking research exploring consumer behavior towards snacking (food and beverage).  Of particular interest is new research in flavor, texture and visual cues and changes with age and attitude.  Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 11/25).
  • PepsiCo is seeking technologies to reduce Greenhouse gas emissions during packaging production or over the lifecycle of PET bottles, Aluminum cans and glass packaging without sacrificing packaging quality.  Of particular interest are highly functional materials, additives or coatings to improve packaging properties or reduce energy usage during production.  Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 11/25).
  • PepsiCo is looking for encapsulation technologies for functional beverage ingredients.  Essential requirements include consumer safety, stability, no or minimum sensory impact to final product, and minimum 6 month ingredient shelf-life.   Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 11/25).


NIH Notices 

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.


NIH Funding Opportunities


Other Funding Opportunities

Cystic Fibrosis Foundation Call for Mental Health Research Working Group Members

Description: The mission of the Cystic Fibrosis Mental Health Research Working Group (MHRWG) is to advance our knowledge of mental health conditions in the CF population throughout the lifespan and promote clinical and translational research that will improve the understanding, prevention, diagnosis, and treatment of mental health concerns in CF. The MHRWG is seeking to create a multi-disciplinary group, including, but not limited to, physicians/psychiatrists, psychologists/neuropsychologists, social workers, pharmacists etc., and other specialists with an interest in CF mental health. Applications must be submitted online at For questions, please contact Dara Riva ( and Kayli Davis (

Applications Due: December 14, 2022

Link to Full Announcement:


Cystic Fibrosis Foundation Medical Resident Research Award

Description: The newly launched CF Foundation Medical Resident Research Award is designed to introduce residents to research through participation in a CF-relevant research project with the goal to develop and maintain interest in a career in CF research or as a CF care provider. Awards support up to $10,000 in salary or research related costs for one year and applications are accepted on a rolling basis at For questions, please contact Liz Yu (

Link to Full Announcement:


Primary Care Training and Enhancement - Residency Training in Mental and Behavioral Health (PCTE-RTMB)

Description: The purpose of the PCTE-RTMB program is to train primary care residents in the prevention, identification, diagnosis, treatment, and referral of services for mental and behavioral health conditions for pediatric, adolescent, young adult, and other populations who are at-risk or have experienced abuse, trauma, or mental health and/or substance use disorders, including those related to the effects of gun. Primary care residencies eligible to apply include family medicine, general internal medicine, general pediatrics and combined internal medicine and pediatrics (med-peds) residencies. Funding must be used to support both didactic training and at least a one-month clinical rotation primarily focused on mental and behavioral health conditions. It is encouraged that other rotations beyond the one-month also focus on mental and behavioral health conditions.

Applications Due: November 15, 2022

Link to Full Announcement:


Call for Pre-Proposals Early K99/R00 Funding Opportunity Announcements

NCI just reissued so-called “early K99/R00” - NCI Pathway to Independence Award for Outstanding Early-Stage Postdoctoral Researchers Funding Opportunity Announcements (FOAs).

This Early K99/R00 award in many respects, such as duration, financial support, etc. is similar to the parent K99/R00. However, there are several important differences:

  • Only postdoctoral (or postdoc-like) researchers with less than 2 years of postdoctoral research experience by the submission due date (February 28, 2023) are eligible to apply
  • Each candidate must be nominated by the institution and a nomination letter (2 pgs max) must be included in the application (refer to the FOAs for the requirements)
  • Each institution may submit up to 3 applications, but each application must be in a different field of science: one in data science, one in cancer control science and one in other sciences. Please refer to the FOAs for the field of science definition
  • Early K99/R00 applications are reviewed by a special emphasis panel, therefore, they are not competing with the regular/parent K99/R00.
    • Preliminary data are not required
    • Publication with the current/postdoctoral mentor are not required

Pre-proposal is due to Stevie Warner by November 18, 2022. The Education, Training, and Career Enhancement Core will organize a review committee and select an applicant from each field of science to nominate for submission. This selection and notifications will take place by December 2, 2022 to allow the selected candidates ample time to write their full application.

  • Specific Aims page
  • Biosketch
  • Letter of Support from Mentor

Application Due Date: Submissions must be received by February 28, 2023 at 5:00 PM local time of applicant organization.

Pre-application informational webinar: NCI is planning to hold a pre-application informational webinar on November 7, 2023, 2:00 PM ET

Monday, Nov 7, 2022 2:00 pm | 1 hour | (UTC-04:00) Eastern Time (US & Canada)

Meeting number: 2311 987 0275

Password: aQW7Nyd74g@

Join by video system


You can also dial and enter your meeting number.

Join by phone

1-650-479-3207 Call-in toll number (US/Canada)

Access code: 231 198 70275


The Leona M. and Harry B. Helmsley Charitable Trust’s (Helmsley) Type 1 Diabetes (T1D) Program

Description: The Leona M. and Harry B. Helmsley Charitable Trust’s (Helmsley) Type 1 Diabetes (T1D) Program is launching a Request for Proposals (RFP) to support the development of novel, real-world solutions to help people with T1D exercise safely and to improve their quality of life. Researchers and clinicians are expected to partner with statistical teams to analyze the real-world data that was collected under Helmsley’s T1D Exercise Initiative (T1-DEXI), build collaborations with other necessary third parties, and to test their novel solutions in studies with people with T1D. The overarching purpose of this initiative is to move real-world data towards real-world solutions.

 Concept Notes due: April 30, 2023

Link to Full Announcement:


Cystic Fibrosis Foundation Idea Development Award

Description: The Spring 2023 Idea Development Award (IDA) is intended to support work that leads to sufficient project development to enable an application for future research funding from the Cystic Fibrosis Foundation or the National Institutes of Health. For more information, visit the IDA webpage.  For questions, please contact Dara Riva (

Applications Due: February 2, 2023

Link to Full Announcement:

Documents to download